Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Toro-Tobon D, Singh Ospina N, Brito JP. Thyroid 2025 Jan 8. doi: 10.1089/thy.2024.0690.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Toro-Tobon D, Singh Ospina N, Brito JP. Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid 2025 Jan 8. doi: 10.1089/thy.2024.0690.
PMID: 39772719